NomoCan Pharmaceuticals logo

NomoCan Pharmaceuticals

NomoCan Pharmaceuticals offers first-in-kind targeted therapies for some of the most aggressive cancers with unmet medical need. Our platform technology not only makes available a selective and specific diagnostic and prognostic test for early detection, but more remarkably, it introduces a highly effective monoclonal antibody (mAb) drugs for the treatment of various cancers in order to “Bring Hope” to patients affected by this devastating disease.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://www.nomocan.com
Founded2013
Disease Focus
Development Stage
STOCK CODENon Listed
Address
310 E 67th Street, Suite 1-45, NY 10065
New York
United States
Email
Contact Number

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://in.linkedin.com/company/nomocan-pharmaceuticals” connections=”true” suffix=””]